New Zealand Gazette – 1997 – No. 158

Page 3716

✨ Health and Food Standards Notices



3716 NEW ZEALAND GAZETTE No. 158

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Meglumine gadoterate 377 mg/mL equivalent to 279.3 mg/mL gadoteric acid in 5 mL Injection, ampoule Laboratoires Guerbet, Alnay-sous-Bois, France Dotarem
Meglumine gadoterate 377 mg/mL equivalent to 279.3 mg/mL gadoteric acid in 15 mL, 20 mL Injection, prefilled syringe Laboratoires Guerbet, Alnay-sous-Bois, France Dotarem
Meglumine gadoterate 377 mg/mL equivalent to 279.3 mg/mL gadoteric acid in 10 mL, 15 mL, 20 mL Injection, bottle Laboratoires Guerbet, Alnay-sous-Bois, France Dotarem
Bromhexine hydrochloride 0.8 mg/mL in 100 mL, 200 mL Liquid, oral 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia Dur-Elix
Bromhexine hydrochloride 0.8 mg/mL, pseudoephedrine hydrochloride 4 mg/mL in 100 mL, 200 mL Liquid, oral 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia Dur-Elix Plus
Cefepime hydrochloride 601 mg, 1.202 g, 2.404 g equivalent to 500 mg in 15 mL, 1 g in 15 mL, 2 g in 77 mL cefepime Injection, powder for, vial Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy and Bristol-Myers Squibb Barceloneta Inc., Barceloneta, Puerto Rico Maxipime
Cefepime hydrochloride 1.202 mg, 2.404 g equivalent to 1 g, 2 g cefipime in 100 mL Injection, powder for, bottle Bristol-Myers Squibb SpA., Sermoneta, Latina, Italy and Bristol-Myers Squibb Barceloneta Inc., Barceloneta, Puerto Rico Maxipime
Dextromethorphan hydrobromide 1 mg/mL, mepyramine maleate 1.67 mg/mL, paracetamol 21.67 mg/mL, pseudoephedrine hydrochloride 2 mg/mL in 25 mL, 30 mL, 100 mL, 200 mL Elixir Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin Night Relief
Yellow fever virus strain 17 D/AB 237 live, stabilised not less than 1000 mouse LD₅₀ units in 0.5 mL; and sodium chloride 2 mg in 0.5 ml as diluent Vaccine, injection, ampoule and vial; Diluent, single dose syringe Pasteur Merieux Serums et Vaccins SA., Marcy L’Etoile, France and Pasteur Merieux Serums et Vaccins, Val-De-Reuil Cedex, France Stamaril

Dated this 31st day of October 1997.

G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on 20 February 1997.

g07931

Food Act 1981

Inspection at the Ministry of Health, 133 Molesworth Street, Wellington.

The New Zealand Food Standard 1996, Amendment No. 5
Section 11c of the Food Act 1981

The New Zealand Food Standard 1996, Amendment No. 5 was issued by the Minister of Health on 1 November 1997.

This standard, and the material incorporated by reference in this standard, i.e., the Australian Food Standards Code, up to and including Amendment No. 36, is available for inspection at the Ministry of Health, 133 Molesworth Street, Wellington.

Copies of both the New Zealand Food Standard 1996 and the Australian Food Standards Code, and their amendments, are available for purchase from any Bennetts Government Bookshop.

The New Zealand Food Standard 1996, Amendment No. 5, will come into force on the 28th day after the date of this notification.

g07934



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa — PDF NZ Gazette 1997, No 158


NZLII — PDF NZ Gazette 1997, No 158




✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
31 October 1997
Medicines Act 1981, New Medicines, Distribution Consent, Schedule
  • G. R. Boyd, Chief Advisor, Regulation and Safety

🏥 Food Standard Amendment Notification

🏥 Health & Social Welfare
Food Act 1981, New Zealand Food Standard 1996, Amendment No. 5, Australian Food Standards Code